Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto Lopes

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Health Affairs (Project Hope)|May 6, 2009
Rewarding innovation in drug discoveryGilberto Lopes
JAMA Oncology|February 23, 2023
The Global Economic Cost of Cancer-Estimating It Is Just the First Step!Gilberto Lopes
JAMA Oncology|June 4, 2026
Georgia O'Keeffe, Hannah Wilke, and Choosing One's Own Narrative-SovereigntyGilberto Lopes
Nature Reviews. Clinical Oncology|March 1, 2020
Upfront osimertinib - winner takes it all?Jordi Remon, Gilberto Lopes
Journal of Global Oncology|March 16, 2018
Coming on Its Own, Global Oncology ResearchOphira Ginsburg, Gilberto Lopes
The Oncologist|December 14, 2011
Weighed, measured, and still searching: bevacizumab in the treatment of unselected patients with advanced breast cancerGilberto Lopes, Rebecca Dent
Journal of Global Oncology|November 3, 2017
Improving Access to Cancer Treatments: The Role of BiosimilarsRakesh Chopra, Gilberto Lopes
Clinical Lung Cancer|January 27, 2019
Perspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non-Small-Cell Lung CancerWungki Park, Gilberto Lopes
Journal of Global Oncology|September 23, 2018
What Global Oncology Needs: Mutual Learning and More FundingBishal Gyawali, Gilberto Lopes
The Lancet. Respiratory Medicine|June 19, 2019
How sustainable are new treatment strategies for NSCLC?Jordi Remon, Gilberto Lopes, Carlos Camps
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Health Affairs (Project Hope)|May 6, 2009
Rewarding innovation in drug discoveryGilberto Lopes
JAMA Oncology|February 23, 2023
The Global Economic Cost of Cancer-Estimating It Is Just the First Step!Gilberto Lopes
JAMA Oncology|June 4, 2026
Georgia O'Keeffe, Hannah Wilke, and Choosing One's Own Narrative-SovereigntyGilberto Lopes
Nature Reviews. Clinical Oncology|March 1, 2020
Upfront osimertinib - winner takes it all?Jordi Remon, Gilberto Lopes
Journal of Global Oncology|March 16, 2018
Coming on Its Own, Global Oncology ResearchOphira Ginsburg, Gilberto Lopes
The Oncologist|December 14, 2011
Weighed, measured, and still searching: bevacizumab in the treatment of unselected patients with advanced breast cancerGilberto Lopes, Rebecca Dent
Journal of Global Oncology|November 3, 2017
Improving Access to Cancer Treatments: The Role of BiosimilarsRakesh Chopra, Gilberto Lopes
Clinical Lung Cancer|January 27, 2019
Perspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non-Small-Cell Lung CancerWungki Park, Gilberto Lopes
Journal of Global Oncology|September 23, 2018
What Global Oncology Needs: Mutual Learning and More FundingBishal Gyawali, Gilberto Lopes
The Lancet. Respiratory Medicine|June 19, 2019
How sustainable are new treatment strategies for NSCLC?Jordi Remon, Gilberto Lopes, Carlos Camps
Pageof 18